The full video by Dr. David Price of Weill Cornell Medical Center in New York City has gone viral. It’s about an hour long. Here’s a much easier to watch, edited, short version with just the most important part – the best advice on how not to get the virus:
MEDICINE & SCIENCE
-
-
A global survey found that anti-malarial drug hydroxychloroquine was the most highly-rated treatment against the coronavirus disease 2019 (COVID-19). This new survey completed by Sermo on March 27, 2020, reported 6,227 physicians in 30 countries found that 37 percent of those treating COVID-19 patients rated hydroxychloroquine as the “most effective therapy” from a list of 15 options. Also, the survey of 6,227 doctors found that the most commonly prescribed treatments are 56% analgesics, 41% Azithromycin, and 33% Hydroxychloroquine.
-
The Science Says #MaskUp – A Look At Two New Virus Studies
25 minutes readMoA—A person rarely gets infected by just one virus particle. They come in millions attached to tiny droplets. We do not know yet how the dose of the novel coronavirus that infects a person affects the intensity of the disease. But we do know from other viruses that the dose matters. People who catch a higher dose of viruses will usually have a more intense disease. A mask can lower the virus load the wearer may receive. One can improvise a mask from simple household objects.
-
In search of a coronavirus killer: Can existing drugs really turn the tide in the Covid-19 pandemic?
23 minutes readRT.COM—A drug called remdesivir, originally developed to treat the Ebola virus, has been another widely discussed treatment option. Designated an ‘orphan drug’ (one which treats extremely rare conditions and is therefore commercially underdeveloped) by the FDA, remsedivir emerged as one of the “most promising” treatments in numerous Western media reports. In the US, the Pentagon even rushed to secure doses of the experimental drug for US troops who have contracted the virus.
-
ALICE McCARTHY—According to the World Health Organization, older people and people with preexisting medical conditions appear to be more vulnerable to becoming severely ill with COVID-19.
“Elderly individuals have a different immune system than healthy middle-aged adults and often do not respond as robustly to immunization, so a one-size vaccine does not fit all,” said Ofer Levy, professor of pediatrics at Harvard Medical School and director of the PVP.